Vidal-Crespo, A., Rodriguez, V., Matas-Cespedes, A., Lee, E., Rivas-Delgado, A., Giné, E., . . . Pérez-Galán, P. (2017). The Bruton tyrosine kinase inhibitor CC-292 shows activity in mantle cell lymphoma and synergizes with lenalidomide and NIK inhibitors depending on nuclear factor-κB mutational status. Haematologica.
Trích dẫn kiểu ChicagoVidal-Crespo, Anna, et al. "The Bruton Tyrosine Kinase Inhibitor CC-292 Shows Activity in Mantle Cell Lymphoma and Synergizes With Lenalidomide and NIK Inhibitors Depending On Nuclear Factor-κB Mutational Status." Haematologica 2017.
Trích dẫn MLAVidal-Crespo, Anna, et al. "The Bruton Tyrosine Kinase Inhibitor CC-292 Shows Activity in Mantle Cell Lymphoma and Synergizes With Lenalidomide and NIK Inhibitors Depending On Nuclear Factor-κB Mutational Status." Haematologica 2017.